Related Experiment Video
Updated: May 5, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 27, 2016
Diphenhydramine: It is time to say a final goodbye
James H Clark1, Eli O Meltzer2, Robert M Naclerio1
1Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Diphenhydramine, a first-generation antihistamine, poses greater public health risks than newer alternatives. Its use should be restricted due to a higher adverse effect profile, especially in children and the elderly.
Area of Science:
- Pharmacology
- Public Health
Background:
- Diphenhydramine was a pioneering antihistamine but is now surpassed by second-generation options.
- Second-generation antihistamines offer similar efficacy with improved safety profiles.
Purpose of the Study:
- To evaluate the current therapeutic ratio and public health implications of diphenhydramine.
- To assess the continued appropriateness of diphenhydramine's widespread availability.
Main Methods:
- Comprehensive evaluation of clinical practice patterns.
- Analysis of the prevalence and incidence of adverse clinical events associated with diphenhydramine.
Main Results:
- Diphenhydramine exhibits a problematic therapeutic ratio, with higher adverse effects in children and older adults.
- Despite risks, diphenhydramine is available in over 300 formulations, many over-the-counter.
Conclusions:
- Diphenhydramine has reached the end of its therapeutic life cycle.
- It represents a significant public health hazard compared to other antihistamines.
- Recommendations include restricting its prescription and over-the-counter availability.
More Related Videos
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drug Dosing: Geriatric Patients
Drug Toxicity: Dose-Dependent Reactions

